| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 390,099 | 362,105 | 217,892 | 949,207 | | Cost of Revenue | 260,269 | 242,409 | 156,730 | 812,888 | | | Gross Profit | 129,830 | 119,696 | 61,162 | 136,319 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (130,565) | 77,768 | 40,856 | 58,738 | | Non Recurring | 225,605 | (205,296) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 34,790 | 247,224 | 20,306 | 77,581 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 34,791 | 50,388 | (96,382) | (145,205) | | Earnings Before Interest And Taxes | 69,581 | 297,612 | (76,076) | (67,624) | | Interest Expense | 10,568 | 29,208 | 11,740 | 4,247 | | Income Before Tax | 59,013 | 268,404 | (87,816) | (71,871) | | Income Tax Expense | 11,584 | 52,339 | (17,564) | (4,992) | | Minority Interest | (405) | (1,780) |
-
| (4,721) | | | | Net Income From Continuing Ops | 47,979 | 214,738 | (88,673) | (82,591) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 47,146 | 214,738 | (88,673) | (82,591) | | Preferred Stock And Other Adjustments |
-
| (1,012) | 1,012 |
-
| | | Net Income Applicable To Common Shares | $47,146 | $213,726 | ($87,661) | ($82,591) |
|
0.31% Nasdaq 0.00%
Income Statement
